XML 18 R7.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements Of Cash Flows - USD ($)
6 Months Ended
Aug. 27, 2021
Aug. 28, 2020
OPERATING ACTIVITIES    
Net income (loss) $ (3,400,000) $ 17,400,000
Depreciation and amortization 41,200,000 43,300,000
Goodwill, Impairment Loss 0 17,600,000
Restructuring Charges 0 15,600,000
Increase (Decrease) in Deferred Income Taxes (3,100,000) 18,000,000.0
Non-cash stock compensation 15,200,000 9,700,000
Equity in income of unconsolidated affiliates (2,100,000) (3,900,000)
Dividends received from unconsolidated affiliates 4,000,000.0 2,800,000
Other (19,400,000) (12,500,000)
Changes in operating assets and liabilities net of acquisitions:    
Accounts receivable (58,000,000.0) 58,000,000.0
Inventories (42,000,000.0) (200,000)
Other assets (20,300,000) (10,800,000)
Accounts payable 54,700,000 (36,500,000)
Employee compensation liabilities (30,700,000) (120,800,000)
Employee benefit obligations (14,900,000) (24,900,000)
contract with customer, increases in liability due to deposits received 14,000,000.0 74,300,000
Accrued Liabilities and Other Operating Liabilities 3,200,000 (2,200,000)
Net cash provided by operating activities (61,600,000) 44,900,000
INVESTING ACTIVITIES    
Capital expenditures (31,800,000) (18,000,000.0)
Proceeds from Sale of Property, Plant, and Equipment 16,800,000 7,100,000
Other 8,500,000 4,900,000
Net cash provided by (used in) investing activities (6,500,000) (6,000,000.0)
FINANCING ACTIVITIES    
Dividends paid (29,200,000) (20,100,000)
Common stock repurchases (30,900,000) (42,300,000)
Proceeds from Lines of Credit 0 250,000,000.0
Repayments of Lines of Credit 0 (250,000,000.0)
Proceeds from (Payments for) Other Financing Activities (200,000) 1,400,000
Net cash used in financing activities (59,900,000) (63,800,000)
Effect of exchange rate changes on cash and cash equivalents (600,000) 200,000
Net decrease in cash, cash equivalents and restricted cash (128,600,000) (24,700,000)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [1] 495,600,000 547,100,000
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [2] 367,000,000.0 522,400,000
Restricted Cash $ 6,300,000 $ 6,500,000
Document Period End Date Aug. 27, 2021  
Fair Value, Recurring [Member]    
Restricted Cash $ 6,300,000  
Fair Value, Inputs, Level 1 | Fair Value, Recurring [Member]    
Restricted Cash $ 6,300,000  
[1] These amounts include restricted cash of $5.8 and $6.1 as of February 26, 2021 and February 28, 2020, respectively.
[2] These amounts include restricted cash of $6.3 and $6.5 as of August 27, 2021 and August 28, 2020, respectively.Restricted cash primarily represents funds held in escrow for potential future workers’ compensation and product liability claims.  Restricted cash is included as part of Other assets in the Condensed Consolidated Balance Sheets.